Junko Abe, Koichi Yamada, N. Yoshii, Wataru Shibata, Kazuhiro Oshima, H. Kakeya
{"title":"每周一次血液透析患者抗mrsa药物达托霉素给药方案的模拟:透析后72小时间隔前给予1.5倍剂量是否合理?","authors":"Junko Abe, Koichi Yamada, N. Yoshii, Wataru Shibata, Kazuhiro Oshima, H. Kakeya","doi":"10.3999/JSCPT.51.325","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":21491,"journal":{"name":"Rinsho Yakuri\\/japanese Journal of Clinical Pharmacology and Therapeutics","volume":"49 1","pages":"325-330"},"PeriodicalIF":0.0000,"publicationDate":"2020-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Simulation of the Dosing Regimen of the Anti-MRSA Drug Daptomycin in a Patient Receiving Thrice-weekly Hemodialysis: Is It Reasonable to Administer 1.5 Times Dosage before the 72-hour Interval after Dialysis?\",\"authors\":\"Junko Abe, Koichi Yamada, N. Yoshii, Wataru Shibata, Kazuhiro Oshima, H. Kakeya\",\"doi\":\"10.3999/JSCPT.51.325\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":21491,\"journal\":{\"name\":\"Rinsho Yakuri\\\\/japanese Journal of Clinical Pharmacology and Therapeutics\",\"volume\":\"49 1\",\"pages\":\"325-330\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-11-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rinsho Yakuri\\\\/japanese Journal of Clinical Pharmacology and Therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3999/JSCPT.51.325\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rinsho Yakuri\\/japanese Journal of Clinical Pharmacology and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3999/JSCPT.51.325","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Simulation of the Dosing Regimen of the Anti-MRSA Drug Daptomycin in a Patient Receiving Thrice-weekly Hemodialysis: Is It Reasonable to Administer 1.5 Times Dosage before the 72-hour Interval after Dialysis?